The cancer research community is undergoing a paradigm shift from the study of the static, equilibrium properties of macromolecules, towards the analysis of the dynamic, non-equilibrium properties of cells and tissues as aggregate assemblies of macromolecules within the specific context of disease states. Live cell imaging over time allows for analysis of such dynamic processes, and has received considerable attention in recent years. The Large Scale Digital Cell Analysis System (LSDCAS) is a unique system that provides for advanced analyses of live cells overtime in the areas of: 1) Cell Motility, 2) Gene Expression, 3) Cell Death, 4) Intracellular Pro-Oxidant Fluxes, 5) Cell-Cell Interaction. LSDCAS Core Facility personnel provide 1) Consultation to optimize experimental protocols, planning and supervision of all experiments. 2) Analyses of the users'movies (if requested). 3) Training of the users for movie analyses. 4) Development of customized software for any particular application that might need different tools than those already implemented in the LSDCAS Core These unique capabilities are allowing HCCC members from multiple programs to address scientific questions that could not be addressed using standard techniques. Additional capabilities to be implemented will add relational database technology to centralize data and analyses, and will provide web interfaces for the use of collaborators. Moreover, software deconvolution techniques will be developed and added to the public domain code base for the interpretation of combined phase-contrast and fluorescence microscope images

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-10
Application #
7900761
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$98,191
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Grogan, Nicole; Swami, Umang; Bossler, Aaron D et al. (2018) Toxicities with targeted therapies after immunotherapy in metastatic melanoma. Melanoma Res 28:600-604
Meng, Xiangbing; Bi, Jianling; Li, Yujun et al. (2018) AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations. Cancers (Basel) 10:
Klingelhutz, Aloysius J; Gourronc, Francoise A; Chaly, Anna et al. (2018) Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery. Sci Rep 8:523
Tracy, Sean I; Habermann, Thomas M; Feldman, Andrew L et al. (2018) Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression. Haematologica 103:297-303
Zhu, Yueming; Dean, Angela Elizabeth; Horikoshi, Nobuo et al. (2018) Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy. J Clin Invest 128:3682-3691
Ebeid, Kareem; Meng, Xiangbing; Thiel, Kristina W et al. (2018) Synthetically lethal nanoparticles for treatment of endometrial cancer. Nat Nanotechnol 13:72-81
Do, Anh-Vu; Geary, Sean M; Seol, Dongrim et al. (2018) Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing. Int J Pharm 539:139-146
Gold, Joshua M; Stuart, Jillian O'Rourke; Thiem, Kelsey C et al. (2018) The unintended impact of smoking-risk information on concerns about radon: A randomized controlled trial. Health Psychol 37:1123-1133
Sarkar, Koustav; Han, Seong-Su; Wen, Kuo-Kuang et al. (2018) R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol 142:219-234
Ramakrishnan, Sreejith; Kockler, Zachary; Evans, Robert et al. (2018) Single-strand annealing between inverted DNA repeats: Pathway choice, participating proteins, and genome destabilizing consequences. PLoS Genet 14:e1007543

Showing the most recent 10 out of 1080 publications